Atlas Trials

Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID

Clinical trial NCT02999984 · COMPLETED

Trial details

NCT number
NCT02999984
Sponsor
University of California, Los Angeles
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Severe Combined Immunodeficiency Due to ADA Deficiency
Start date
2016-12-16
Primary completion
2018-10-11
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.